داروسازی زاگرس فارمد پارس
ددام | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Income Statement
AGM
Interim
2026/06/22 Fiscal Year 2026/03/2012 Month | 2025/06/01 Fiscal Year 2025/03/2012 Month | 2024/06/08 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 9.754 Trillion | 7.765 Trillion | 6.429 Trillion | |
Total Revenues | 9.754 Trillion | 7.765 Trillion | 6.429 Trillion | |
Cost of Goods Sold | 5.381 Trillion | 4.67 Trillion | 3.364 Trillion | |
Gross Profit | 4.374 Trillion | 3.095 Trillion | 3.065 Trillion | |
General & Administrative Expenses | 546.133 Billion | 356.43 Billion | 260.24 Billion | |
Net Operating Income & Expenses | -98.178 Billion | -27.075 Billion | -91.335 Billion | |
Operating Profit (Loss) | 3.729 Trillion | 2.712 Trillion | 2.713 Trillion | |
Profit Before Tax | 3.378 Trillion | 2.368 Trillion | 2.312 Trillion | |
Tax | 750.605 Billion | 420.819 Billion | 417.711 Billion | |
Net Profit (Loss) After Tax | 2.627 Trillion | 1.948 Trillion | 1.895 Trillion | |
Retained Earnings at Beginning of Period | 2.13 Trillion | 2.005 Trillion | 949.587 Billion | |
Approved Dividends — Prior Year AGM | -2.003 Trillion | -1.725 Trillion | -839.5 Billion | |
Allocable Profit | 2.754 Trillion | 2.227 Trillion | 2.005 Trillion | |
Legal Reserve | 69.683 Billion | 97.376 Billion | - | |
Approved Dividends — Current Year | 2.101 Trillion | 2.003 Trillion | 1.725 Trillion | |
Retained Earnings at End of Period | 583.035 Billion | 127.12 Billion | 279.595 Billion |